Benzbromarone (BBM), a medicine used to treat gout, can stabilize the TTR protein to the same degree as therapies used to treat people with familial amyloid polyneuropathy (FAP), a study showed. These findings support the further development of BBM as an alternative treatment for FAP.  The study, “Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer,” was published in the International Journal of Molecular Sciences.  Mutations in the TTR gene — the underlying…

You must be logged in to read/download the full post.